Skip to main content
Premium Trial:

Request an Annual Quote

DiaCarta Clinical Services Laboratory Receives CLIA Certification

NEW YORK (GenomeWeb) – Molecular diagnostics developer DiaCarta announced today that its DiaCarta Clinical Services Laboratory has successfully passed the State of California survey under the Clinical Laboratory Improvement Amendments of 1988.

The lab now has permission to begin offering patient and clinical testing services for its QClamp-based molecular diagnostic. QClamp screens for tumor oncogenic driver and resistance mutations in tumor DNA derived from cancer patients.

The lab is located in Richmond, California, the company said, and specializes in patient testing and clinical trial services for gene mutation and gene expression monitoring, genotyping, and copy number analysis, as well as other molecular diagnostic tests. QClamp utilizes a sequence-specific xeno-nucleic acid clamp that suppresses PCR amplification on wild-type DNA and allows selective amplification of only the mutant template.

"We are very excited about the new addition of CLIA-certified clinical laboratory testing to our suite of product offerings," said Founder and CEO Aiguo Zhang in a statement. "Our CLIA certification is an important regulatory milestone and demonstrates our commitment to quality laboratory testing to provide accurate, reliable, and timely test results."

The company received a CE IVD mark for several of its QClamp line of real-time PCR-based mutation detection kits in February 2014.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.